Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.
Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.
Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.
Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.
Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.
Health Catalyst and MedRhythms aim to develop a digital therapeutic incorporating AI-generated music and sensor data to help stroke survivors walk.
After four years under the radar, Medtronic made its relationship with endoscope maker Karl Storz official "to enable upcoming regulatory filings.”
Genome Medical has raised $23 million to help scale up its patient counseling services for healthcare systems and individuals across the U.S.
The FDA has approved the first medical device to help reduce abdominal pain in adolescents with IBS through the use of nerve stimulation.
Thomas Schinecker, global business head of the division’s burgeoning centralized and point-of-care solutions, will take over as CEO Aug. 1.